What are the differential diagnoses and recommended evaluation and management for a second‑trimester pregnant woman with recurrent fever and anti‑SSA‑positive pleural effusion after infection has been excluded?

Recurrent Fever and Anti-SSA-Positive Pleural Effusion in Second Trimester Pregnancy

Primary Recommendation

In a second-trimester pregnant woman with recurrent fever, anti-SSA positivity, and pleural effusion after infection has been excluded, the most likely diagnosis is systemic lupus erythematosus (SLE) with serositis, and treatment should be initiated with oral prednisolone 30 mg daily, with careful monitoring for disease activity and fetal surveillance. 1

Differential Diagnosis Framework

Most Likely: SLE with Serositis

• Anti-SSA (Ro) antibodies are strongly associated with SLE and neonatal lupus, and pleural effusion with fever in this context suggests active lupus serositis 1
• Pericarditis and pleuritis are common manifestations of SLE that can present with fever and serous effusions 1
• The combination of recurrent fever, pleural effusion, and positive anti-SSA antibodies after excluding infection is highly suggestive of active autoimmune disease 1

Other Considerations to Exclude

• Tuberculosis: Bilateral tubercular pleural effusion can occur in pregnancy and requires pleural fluid culture for acid-fast bacilli, though this typically takes 4 weeks 2
• Malignancy: Unlikely in a young pregnant woman but should be considered if cytology is atypical 3
• Pulmonary embolism: Can cause pleural effusion and should be evaluated with D-dimer (though elevated in pregnancy) and imaging if clinical suspicion is high 4

Essential Diagnostic Evaluation

Immediate Pleural Fluid Analysis Required

• Perform ultrasound-guided thoracentesis using a 21-gauge needle to obtain at least 50 mL of pleural fluid 5, 6
• Send fluid for: protein and LDH (Light's criteria), pH, Gram stain and culture, acid-fast bacilli stain and TB culture, cytology, and cell count with differential 5, 6, 3
• Ultrasound guidance reduces complications and is essential in pregnancy 5, 6

Serological and Laboratory Assessment

• Measure complement levels (C3, C4) and anti-dsDNA antibodies to assess SLE activity; declining complement with rising anti-dsDNA suggests active disease 4
• Monitor urine protein excretion, urine sediment for glomerular hematuria and casts, and serum creatinine to detect lupus nephritis 4
• Serial CRP and inflammatory markers to track disease activity 1

Fetal Surveillance Protocol

• Initiate fetal echocardiography to screen for congenital heart block, as anti-SSA antibodies carry significant risk for this complication 7
• Begin middle cerebral artery (MCA) Doppler surveillance at 16-18 weeks if not already performed, though this is primarily for red cell alloimmunization 7
• Perform detailed anatomical ultrasound with Doppler at 20-24 weeks 4

Treatment Algorithm

If SLE Serositis is Confirmed

First-Line Therapy:

• Oral prednisolone 30 mg daily is the recommended initial dose for active SLE with serositis during pregnancy 1
• This dose has demonstrated rapid improvement in pericarditis and pleuritis with documented safety during pregnancy 1
• Continue hydroxychloroquine if already prescribed, as it controls disease activity and prevents flares 4

Monitoring During Treatment:

• Track clinical response with serial CRP, complement levels, and anti-dsDNA titers 4, 1
• Monitor for hypercoagulability with D-dimer and consider prophylactic low-molecular-weight heparin if levels remain elevated 1
• Assess for preeclampsia, as serological activity increases risk for pregnancy complications 4

Steroid Tapering:

• Do not reduce prednisolone dose until clinical and serological improvement is documented 1
• Gradual taper only after resolution of fever, effusion, and normalization of inflammatory markers 1

If Tubercular Pleural Effusion is Diagnosed

• Initiate anti-tuberculosis therapy immediately upon positive acid-fast bacilli culture 2
• Standard four-drug regimen (isoniazid, rifampin, pyrazinamide, ethambutol) is safe in pregnancy after the first trimester 2
• Therapeutic thoracentesis may be required for respiratory stabilization 2

Critical Pitfalls to Avoid

Do Not Delay Thoracentesis

• Small effusions in pregnancy still require diagnostic aspiration when associated with fever and positive autoantibodies 5, 3
• The presence of pleural friction rub (if present) mandates investigation even if the patient appears stable 5

Do Not Assume Infection is Excluded Without Pleural Fluid Culture

• Tubercular pleural effusion can present with negative initial screening and requires 4 weeks for culture confirmation 2
• Send pleural fluid in blood culture bottles to maximize yield 5, 6

Do Not Withhold Corticosteroids if SLE is Likely

• Prednisolone is safe during pregnancy and prevents maternal morbidity from uncontrolled SLE 1, 4
• Untreated active SLE carries higher risk for pregnancy loss, preterm birth, and intrauterine growth restriction than corticosteroid therapy 4

Do Not Forget Fetal Heart Block Surveillance

• Anti-SSA antibodies confer significant risk for congenital heart block, requiring serial fetal echocardiography 7
• This complication can develop between 16-24 weeks and requires early detection 7

Ongoing Pregnancy Management

Third-Trimester Surveillance

• Monthly ultrasound with Doppler of umbilical artery, uterine arteries, and middle cerebral artery to detect placental insufficiency 4
• Serial growth assessments for intrauterine growth restriction, which is increased with active SLE 4
• Continue serological monitoring every 6-12 weeks throughout pregnancy 4

Delivery Planning

• Coordinate with maternal-fetal medicine and rheumatology for delivery planning 4
• Stress-dose corticosteroids (hydrocortisone 100 mg IV every 8 hours) during labor if patient has been on >20 mg prednisolone daily for >3 weeks 4